Clinical Trials Browser

Withdrawn × Liver Neoplasms × Doxorubicin × Clear all

NCT02853500 2025-02-05

Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies

Phase 4 Withdrawn

Gastrointestinal

Liver Neoplasms